[ad_1] NEW YORK, Nov. 13, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers…
Tag: Delcath Systems
Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
[ad_1] A Retrospective Comparative Study of SIRT and CS-PHP for Liver Targeted Therapy of Patients with Metastatic Uveal Melanoma NEW YORK, Aug. 29, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq:…
Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update
[ad_1] NEW YORK, Aug. 9, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers…